| psoriasis epidemiology screening tool |
483 |
| psoriasis |
483 |
| psoriatic arthritis |
483 |
| screening questionnaire |
483 |
| ankle-brachial index |
495 |
| carotid intima-media thickness |
495 |
| heart disease risk factors |
495 |
| systemic lupus erythematosus |
495, 504, 527, 566, 626 |
| vascular stiffness |
495 |
| cytochrome c oxidase subunits 1 |
504 |
| malondialdehyde |
504 |
| oxidative stress |
504 |
| carpal tunnel syndrome |
517 |
| steroid phonophoresis |
517 |
| ultrasound |
517 |
| disease activity |
527, 593 |
| lupus nephritis |
527 |
| urinary plasmin |
527 |
| gouty arthritis |
536 |
| inflammation |
536 |
| mirna-23a-5p |
536 |
| myd88 |
536 |
| nf-&kappa |
536 |
| b |
536 |
| tlr2 |
536 |
| clinical examination |
547 |
| juvenile idiopathic arthritis |
547 |
| magnetic resonance imaging |
547 |
| shoulder joint |
547 |
| coronaphobia |
559 |
| physical activity |
559, 603 |
| rheumatoid arthritis |
559, 603, 613 |
| complement receptor 2 |
566 |
| mutation |
566 |
| sequencing |
566 |
| cervical radiculopathy |
574 |
| disability evaluation |
574 |
| herniated disc |
574 |
| pain measurement |
574 |
| questionnaire |
574 |
| dyslipidemia |
584 |
| gene polymorphism |
584 |
| low-density lipoprotein cholesterol |
584 |
| lupus |
584 |
| nephritis |
584 |
| abnormal lipid level |
593 |
| insulin resistance |
593 |
| very early rheumatoid arthritis |
593 |
| kinesiophobia |
603 |
| remission |
603 |
| pain |
603 |
| etanercept |
613 |
| genetic polymorphism |
613 |
| response |
613 |
| tumor necrosis factor-alpha |
613 |
| anti-double-stranded deoxyribonucleic acid |
626 |
| antinuclear antibody |
626 |
| antiphospholipid antibody |
626 |
| complement |
626 |
